
Alvaro Moreno-Aspitia MD
Breast Cancer, Hematologic Oncology
Professor of Medicine, Mayo Medical School
Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Moreno-Aspitia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1997 - 2000
Texas AM College of Medicine-Scott and White Medical CenterResidency, Internal Medicine/Pediatrics, 1993 - 1997
Universidad Nacional de Asuncion Faculty of MedicineClass of 1991
Certifications & Licensure
FL State Medical License 1998 - 2028
KY State Medical License 2025 - 2027
OK State Medical License 2025 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Mayo Distinguished Clinician Mayo Clinic, 2021
- CMS Meaningful Use Stage 1 Certification FirstNet (Image Results), Cerner Corporation, 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2014-2015, 2017
Clinical Trials
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Start of enrollment: 2017 Mar 31
- Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2019 Aug 28
Roles: Contact, Principal Investigator
- Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer Start of enrollment: 2022 May 27
Roles: Contact
Publications & Presentations
PubMed
- 2 citationsPembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.Saranya Chumsri, Joseph J Larson, Emily Liu, Kathleen S Tenner, Daniel Adams
Clinical Cancer Research. 2025-05-15 - Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy.Andrew Liu, Brian Necela, Zhuo Li, Davitte Cogen, Mikolaj A Wieczorek
Frontiers in Immunology. 2025-01-01 - 1 citationsClinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer.Saranya Chumsri, Tanmayi Pai, Yaohua Ma, Zhuo Li, Angelica Gil
Journal of the National Comprehensive Cancer Network. 2024-08-26
Journal Articles
- Adjuvant Chemotherapy: To Use or Not To Use, The AnthracyclinesCrozier JA, Swaika A and Moreno-Aspitia A, World J Clin Oncol, 8/1/2014
- Current strategies for the prevention of breast cancerAdvani P and Moreno-Aspitia A, Breast Cancer: Targets and Therapy, 1/1/2014
- A church-based, Spanish language community education breast health program increases awareness and utilization of breast diagnostic services among HispanicColon-Otero G, Albertie M, Rodriguez J, et al (Moreno-Aspitia A), Journal of Higher Education Outreach and Engagement, 1/1/2014
Books/Book Chapters
Abstracts/Posters
- Clonal selection of neoplastic cells in patients with resistance to neo-adjuvant chemotherapy. Poster presentation.Goetz MP, Barrett M, Kalari KR, et al (Moreno-Aspitia A), San Antonio Breast Cancer Symposium, 12/1/2014
- Identification of actionable germline mutations in women newly diagnosed with high risk breast cancer enrolled in the Breast cancer genome guided therapy study (BEAUTY).Ellingson MS, Schahl KA, Kalari KR, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
- Gene expression analysis in triple-negative breast cancers following neoadjuvant chemotherapy.Kalari KR, Suman VJ, Sinnwell JP, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
Lectures
- Advances in Breast Cancer TreatmentJacksonville, FL - 10/4/2014
- Metastatic Breast CancerMayo Clinic, Jacksonville, FL - 1/1/2014
- Introduction to ChemotherapyMayo Clinic, Jacksonville, FL - 1/1/2014
Other
- Breast Cancer Update. TV PresentationsMoreno-Aspitia A, CNN en Espanol
10/1/2011 - Update on Antiangiogenic Therapy for Advanced Breast CancerMoreno-Aspitia A, Boston University School of Medicine and the Angiogenesis Foundation
http://www.angio.org/cme/breast4.php
1/1/2011
Press Mentions
ALTTO Follow-up: Dual HER2 Blockade May Benefit HER2+/HR- TumorsJune 26th, 2017
Professional Memberships
- Member
- Fellow
- Fellow
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









